Metsera, Inc. Prices Initial Public Offering at $18.00 per Share ...
2 days ago · Metsera, Inc. prices its IPO at $18 per share, raising approximately $275 million to fund obesity treatments. Quiver AI Summary. Metsera, Inc., a clinical-stage biotechnology …
Weight-loss drug developer Metsera raises $275 million in US IPO
2 days ago · New York City-based Metsera sold 15.28 million shares above its targeted range at $18 apiece. The company had initially marketed 17.19 million shares at a range of $15 to $17 …
Metsera, Maze go public with IPOs of $275M, $113M
1 day ago · Metsera eyes $289M IPO to fund phase 3 weight loss trial. Meanwhile, Maze’s final share price fell squarely in the middle of the $15-$17 range it set out recently, while it raised …
Metsera Announces Pricing of Initial Public Offering
2 days ago · Metsera prices IPO at $18 per share. Seeking Alpha 1d. Metsera Announces Pricing of Initial Public Offering. GlobeNewswire 2d. Start Trading Futures Related Stocks. MTSR. …
Drugmakers Metsera and Maze Raise Combined $415 Million in …
2 days ago · Metsera Inc. raised $275 million in its IPO, selling 15.3 million shares for $18 each, according to a statement Bloomberg Terminal It had offered 17.2 million shares for $15 to $17 …
Metsera Announces Pricing of Initial Public Offering
2 days ago · In addition, Metsera has granted the underwriters a 30-day option to purchase up to an additional 2,291,666 shares of common stock at the initial public offering price less …
Metsera Readies $275 Million IPO For Obesity Treatments
4 days ago · Metsera intends to raise $275 million in gross proceeds from an IPO of its common stock, offering approximately 17.19 million shares at a proposed midpoint price of $16.00 per …
Metsera eyes $289M IPO to fund phase 3 weight loss trial
5 days ago · This morning also saw Maze Therapeutics outline plans for a $131 million IPO, while Hong Kong-listed Ascentage Pharma joined the Nasdaq via a $126.4 million offering on …
Weight-loss drug developer Metsera targets up to $1.78 billion ...
5 days ago · Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S. IPO, aiming to capitalize on Wall Street's insatiable …
Google Ventures-Backed Biotech Metsera Seeks $292 Million in IPO
5 days ago · Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to make their debuts as public companies. The New York-based …
- Some results have been removed